Evidence map›Paper›PMID 36746813›Full record

ArticleLung2023

Tiotropium in Patients with Bronchiectasis: A Prospective Cohort Study.

Zu-Liang Shi, Hong-Ying Zhang, Hai-Bo Peng, Zhong-Ming Zhu

Abstract read
PubMed Publisher
In one paragraph

Article in Lung, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Zu-Liang Shi *Department of Respiratory Medicine, Dongcheng Branch of First Affiliated Hospital of Anhui Medical University (Feidong People's Hospital), Yao Gang Road, Feidong, 231600, Anhui, People's Republic of China.
Hong-Ying Zhang *Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, 218 Jixi Road, Hefei, 230022, Anhui, People's Republic of China.
Hai-Bo PengDepartment of Respiratory Medicine, Dongcheng Branch of First Affiliated Hospital of Anhui Medical University (Feidong People's Hospital), Yao Gang Road, Feidong, 231600, Anhui, People's Republic of China.
Zhong-Ming ZhuDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, 218 Jixi Road, Hefei, 230022, Anhui, People's Republic of China. Szl202211@163.com.
Anhui Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThere are limited studies on the use of bronchodilators for the treatment of bronchiectasis. This study investigated the efficacy of tiotropium in patients with bronchiectasis and airflow limitation.

methodsThis study was a prospective cohort study, including 169 patients with bronchiectasis and airflow limitation from 2015 to 2019. The clinical outcomes observed in our study were the effect of tiotropium on the frequency of moderate exacerbations, the time to the first severe exacerbation, and the annual decline in FEV

resultsAfter 12 months, the annual decline in the FEV

conclusionIn conclusion, prospective cohort study showed that tiotropium effectively ameliorated the annual decline in the FEV

Indexed as

BronchiectasisPulmonary Disease, Chronic ObstructiveBronchodilator AgentsHumansProspective StudiesScopolamine DerivativesTiotropium BromideTreatment OutcomeBronchodilator AgentsScopolamine DerivativesTiotropium BromideBronchiectasisBronchodilatorsCohort studyTiotropium

Identifiers

PMID36746813
OpenAlexW4319299602

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.